RPT NYSE Week ended 07 Aug 2026

Weekly Investor Report

Rithm Property Trust Inc. · Real Estate · Reit - Mortgage

Open interactive chart View report data
Latest close 12.06 USD
-2.1% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -13.5% below the Trend Line and sits at 30.9% of its 52-week range. The latest completed week returned -2.1%, after a -15.0% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 49/100. Near-term considerations: volume confirmation is below normal.

Setup score 19 out of 100
Latest Close 12.06 USD 7 Aug 2026
1W Return -2.1% latest completed week
4W Return -15.0% short-term follow-through
12W Return -15.5% quarterly tape
Trend Breadth 19.2% 10 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.1% Latest completed week; four-week move -15.0%. Indicator stack 11/15 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 49/100 53 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -13.5% below the Trend Line and sits at 30.9% of its 52-week range. The latest completed week returned -2.1%, after a -15.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1412-week average 0.16

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.14Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -15.0% over four weeks, -15.5% over 12 weeks, and -16.1% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-2.1%
4W-15.0%
12W-15.5%
26W-20.9%
52W-16.1%
Active trend streak0 weeks
Active weeks in one year10
Trend breadth19.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.81Latest activity-pressure read.
Pressure change-253.2%Four-week change in activity pressure.
Leadership-24.85Latest relative-leadership reading.
RS change-108.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 30 Jun 2026 Field coverage 94% Model confidence 94%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength7/100Blend of value, momentum, and quality. Underlying universe rank 94; rank 1 is best.
Value27/100Relative valuation strength. Underlying universe rank 74; rank 1 is best.
Quality11/100Profitability and accounting quality. Underlying universe rank 90; rank 1 is best.
Momentum22/100Medium-term price momentum. Underlying universe rank 79; rank 1 is best.
Growth31/100Revenue and earnings growth. Underlying universe rank 70; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
31.4x
Price divided by trailing earnings.
Price / sales
1.9x
Market value relative to trailing revenue.
EV / EBITDA
62.1x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-1.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
67.3%
Gross profit retained from each unit of revenue.
Operating margin
44.8%
Operating profit retained from revenue.
Free-cash-flow margin
-20.9%
Free cash flow generated from revenue.
Return on invested capital
2.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
39.6%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
14.9%
Cash dividends relative to market value.
Buyback yield
-54.1%
Net share repurchases relative to market value.
Shareholder yield
-39.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
49.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment49/100

Weighted news tone is neutral across 53 relevant articles.

6 positive · 36 neutral · 11 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-29.6%Distance below the 52-week high.
13-week volatility7.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+6.9%Week of 24 Jul.
Worst week-23.3%Week of 17 Jul.
Latest week-2.1%Week of 7 Aug.

Shape of recent returns

Strong gains4
Modest gains8
Flat weeks0
Modest losses12
Sharp losses2
Recent vol7.2%13-week weekly-return volatility.
Base vol4.8%52-week weekly-return volatility.
Up/down split26/25Count of positive and negative weeks in the 52-week window.
Average skew3.1% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape20/100

Trend, activity pressure, participation, and risk combine to a 20/100 tape read.

 Indicator analysis27/100

Latest 12-week confirmation: trend 0/12, activity pressure 9/12, relative leadership 0/12.

Activity pressure 0.14; No reversal markers Factors15/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 97; Small Cap Core rank 78 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment49/100

Weighted news tone is neutral across 53 relevant articles.

Top Medical Properties Trust (MPT) Competitors 2026 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202612.06 USD-2.1%13.95 USD17.38 USD-0.81-24.85400.8KOff
31 Jul 202612.32 USD5.8%14.06 USD17.49 USD-0.45-21.07501.3KOff
24 Jul 202611.64 USD6.9%14.17 USD17.60 USD-0.09-25.061.4MOff
17 Jul 202610.89 USD-23.3%14.29 USD17.72 USD0.25-30.771.3MOff
10 Jul 202614.19 USD-1.1%14.45 USD17.84 USD0.53-11.92256.8KOff
3 Jul 202614.34 USD5.2%14.51 USD17.95 USD0.52-10.20191.7KOff
26 Jun 202613.63 USD-3.0%14.54 USD18.05 USD0.47-13.19930.5KOff
19 Jun 202614.05 USD-2.4%14.60 USD18.13 USD0.44-13.0693.0KOff
12 Jun 202614.40 USD1.6%14.62 USD18.19 USD0.51-10.4997.7KOff
5 Jun 202614.18 USD-3.2%14.61 USD18.26 USD0.42-11.81106.2KOff
29 May 202614.64 USD0.8%14.59 USD18.33 USD0.31-11.6491.0KOff
22 May 202614.53 USD1.8%14.60 USD18.39 USD0.11-11.51144.3KOff
15 May 202614.27 USD-2.2%14.58 USD18.44 USD-0.16-12.79124.7KOff
8 May 202614.59 USD1.5%14.56 USD18.50 USD-0.31-11.12108.9KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context